CareDx Expects Third Quarter 2024 Revenue Of $82M-$83M, Up Approximately 23% YoY, Versus Consensus Of $79.53M
Portfolio Pulse from Benzinga Newsdesk
CareDx anticipates Q3 2024 revenue of $82M-$83M, surpassing consensus estimates. Testing services volume grew by 16% YoY, with revenue expected to rise by 26%. The company ended the quarter with $240M in cash and no debt.
October 15, 2024 | 10:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CareDx projects Q3 2024 revenue of $82M-$83M, exceeding consensus estimates. Testing services revenue is expected to grow by 26% YoY. The company maintains a strong cash position with $240M and no debt.
CareDx's projected revenue for Q3 2024 exceeds consensus estimates, indicating strong business performance. The significant growth in testing services revenue and a robust cash position with no debt are positive indicators for investors, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100